SCHEMBL31219600

SCHEMBL31219600

Cc1c(Br)ncc2c1cnn2COCC[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.37
F2RL1 P55085 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31219661 0.82 DGAT1 (0.31) DGAT1
SCHEMBL24344342 0.82 DGAT1 (0.37) DGAT1
SCHEMBL31276772 0.82 DGAT1 (0.37) DGAT1
SCHEMBL30720732 0.79 DGAT1 (0.37) DGAT1F2RL1
SCHEMBL30706826 0.79 DGAT1 (0.33) DGAT1
SCHEMBL26353142 0.78 DGAT1 (0.34) DGAT1
SCHEMBL25021669 0.78 NPC1 (0.34) DGAT1F2RL1
SCHEMBL19616675 0.76 DGAT1 (0.37) DGAT1
SCHEMBL30709985 0.76 DGAT1 (0.35) DGAT1
SCHEMBL26694764 0.76 DGAT1 (0.35) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713096-A1 CDK INHIBITOR COMPOUNDS Aleksia Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024238574-A1 CDK INHIBITOR COMPOUNDS ALEKSIA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed